BOSTON, July 2 -- Patient response to non-small-cell lung cancer treatment can be assessed by capturing circulating tumor cells with a microchip, a small study showed.   <READ MORE>

PISA, Italy, June 18 -- Radiofrequency ablation of small lung tumors may yield outcomes that rival standard radiation for selected patients ineligible for surgery or other therapy, researchers found in a seven-center trial in Europe, the U.S., and Australia.   <READ MORE>

CHICAGO, June 6 -- In patients with advanced non-small-cell lung cancer, adding an insulin-like growth factor receptor inhibitor to chemotherapy significantly increased overall response and improved progression-free survival, according to results of a phase II study.   <READ MORE>

CHICAGO, June 5 -- Controversy and lack of evidence for a mortality benefit have made physicians reluctant to embrace spiral computed tomography (CT) screening for lung cancer.   <READ MORE>

CHICAGO, June 5 -- After primary chemotherapy, patients with advanced non-small-cell lung cancer had a significant improvement in progression-free survival with pemetrexed (Alimta) maintenance, a large multicenter study showed.   <READ MORE>

CHICAGO, June 5 -- For patients with non-small-cell lung cancer, extending their course of chemotherapy improves progression-free survival but not overall survival and at a cost of more adverse events and reduced quality of life, data from a meta-analysis suggest.   <READ MORE>

CHICAGO, June 5 -- Patients with non-small-cell lung cancer who'd already had several courses of chemotherapy had significant slowing of progression when treated with sorafenib, according to results of a small intergroup trial.  <READ MORE>

CHICAGO, June 5 -- In advanced non-small-cell lung cancer, disease progression slowed significantly when gefitinib (Iressa) was given after first-line chemotherapy, a large Japanese study showed. <READ MORE>

CHICAGO, June 5 -- Irinotecan (Camptosar) plus cisplatin (Platinol) failed to demonstrate a survival benefit in a large North American trial of patients with extensive-stage small-cell lung cancer.  <READ MORE>

CHICAGO, June 2 -- A genetic test may help determine which early stage non-small-cell lung cancer patients can be spared chemotherapy after surgery, researchers said here.  <READ MORE>

CHICAGO, June 1 -- For advanced non-small-cell lung cancer, cetuximab (Erbitux) added to platinum-based chemotherapy increased median survival by five weeks, according to an international study.  <READ MORE>

ROCHESTER, Minn., May 27 -- People with a common genetic mutation have up to twice the risk of lung cancer as do people without the variation, researchers here said.  <READ MORE>

HOUSTON, May 20 -- Long-time smokers showed significant declines in a key marker of abnormal lung cell growth after taking the anti-inflammatory drug celecoxib (Celebrex) for three months, according to interim data from a study here.  <READ MORE>

TORONTO, May 20 -- The active genes in immune cells of patients with non-small cell lung cancer are different than those of healthy patients, a researcher said here.  <READ MORE>

GENEVA, April 25 -- An immune-boosting treatment for non-small-cell lung cancer patients with completely resected stage IB or II disease is safe and well tolerated, researchers said here.  <READ MORE>

Archive 1